Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vasilios Papavasiliou
Observed name:
Papavasiliou, Vasilios
Institutions:
National Technical University of Athens,
Institut du cancer Rosalind & Morris Goodman,
McGill University
Observed institutions:
National Technical University of Athens,
McGill University Health Centre,
Royal Victoria Hospital,
National Cancer Institute,
Institut du cancer Rosalind & Morris Goodman,
McGill University
show all 6
ORCID:
0009-0006-6805-8235
Observed ORCID:
0009-0006-6805-8235
OpenAlex ID:
A5053753256
The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer
2023
·
Tarek Taifour
, Sherif Samer Attalla
, et al.
·
Immunity
·
193
Translational and HIF-1α-Dependent Metabolic Reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides
2018
·
Laura Hulea
, Simon-Pierre Gravel
, et al.
·
Cell Metabolism
·
91
PDF
Parathyroid-hormone-related peptide in hematologic malignancies
1996
·
Richard Kremer
, Chaim Shustik
, et al.
·
The American Journal of Medicine
·
86
Targeting fatty acid oxidation enhances response to HER2-targeted therapy
2024
·
Ipshita Nandi
, Linjia Ji
, et al.
·
Nature Communications
·
70
Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis
2002
·
Caroline Saucier
, Vasilios Papavasiliou
, et al.
·
Oncogene
·
65
Parathyroid hormone–related peptide and survival of patients with cancer and hypercalcemia
2003
·
Ngoc Uyen Truong
, Michael D deB Edwardes
, et al.
·
The American Journal of Medicine
·
60
Elevated Expression of DecR1 Impairs ErbB2/Neu-Induced Mammary Tumor Development
2007
·
Josie Ursini-Siegel
, Ashish B. Rajput
, et al.
·
Molecular and Cellular Biology
·
58
Osteopontin is a therapeutic target that drives breast cancer recurrence
2024
·
Yu Gu
, Tarek Taifour
, et al.
·
Nature Communications
·
57
PDF
Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia
1995
·
Jian Yu
, Vasilios Papavasiliou
, et al.
·
Anti-Cancer Drugs
·
45
An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis
2019
·
Harvey W. Smith
, Alison Hirukawa
, et al.
·
Nature Communications
·
39
PDF
Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression
2023
·
Ipshita Nandi
, Harvey W. Smith
, et al.
·
Journal of Clinical Investigation
·
37
PDF
Nanoliposome targeting in breast cancer is influenced by the tumor microenvironment
2019
·
Nancy Dumont
, Samantha Merrigan
, et al.
·
Nanomedicine Nanotechnology Biology and Medicine
·
31
Expression and regulation of parathyroid hormone-related peptide in normal and malignant melanocytes
2000
·
Khadija El Abdaimi
, Vasilios Papavasiliou
, et al.
·
American Journal of Physiology-Cell Physiology
·
24
HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer
2023
·
Sherif Samer Attalla
, Jonathan Boucher
, et al.
·
Cancer Immunology Research
·
18
Pamidronate prevents the development of skeletal metastasis in nude mice transplanted with human breast cancer cells by reducing tumor burden within bone
2003
·
Khadija El-Abdaimi
, Louis-Georges Ste-Marie
, et al.
·
International Journal of Oncology
·
13
EZH2 directs HER2+ breast cancer progression through the modulation of epithelial plasticity
2026
·
Linshan Liu
, Ellie J Massey
, et al.
·
EMBO Reports
·
6
PDF
The CHI3L1-neutrophil axis drives immune suppression and breast cancer metastatic dissemination
2026
·
Tarek Taifour
, Adéline Massé
, et al.
·
JCI Insight
·
4
HER2∆16 directs luminal cell identity and estrogen receptor signaling in HER2+ breast cancer
2026
·
Hailey Proud
, Elizabeth Podleszanski
, et al.
·
Nature Communications
·
1
Abstract PO2-25-01: Tumor Derived Chitinase-3 like 1 Induces Neutrophil Extracellular Traps that Promote T cell Exclusion and Resistance to Immunotherapies in Breast Cancer
2024
·
Tarek Taifour
, Sherif Samer Attalla
, et al.
·
Cancer Research
·
1
Neutrophil elastase-mediated myoepithelial loss is a therapeutic vulnerability in ductal carcinoma in situ progression
2026
·
Tarek Taifour
, Yu Gu
, et al.
·
Cell Reports Medicine
Upgrade of existing pavement using modified mixes
2026
·
Vasilios Papavasiliou
, Andreas Loizos
·
Transportation research procedia
PDF
Supplementary Data Legends from HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer
2025
·
Sherif Samer Attalla
, Jonathan Boucher
, et al.
Supplementary Figures from HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer
2025
·
Sherif Samer Attalla
, Jonathan Boucher
, et al.
Data from HER2∆16 Engages ENPP1 To Promote an Immune Cold Microenvironment in Breast Cancer
2024
·
Sherif Samer. Attalla
, Jonathan Boucher
, et al.
Supplementary Data Legends from HER2∆16 Engages ENPP1 To Promote an Immune Cold Microenvironment in Breast Cancer
2024
·
Sherif Samer. Attalla
, Jonathan Boucher
, et al.
Show more works
View as search
Works count:
37
Citation count:
899
H-index:
14
I10-index:
15
Year
Topic
Type